Global Peptide Synthesis Market Size, Top Share & Growth Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Peptide Synthesis Market Size Analysis

Global Peptide Synthesis Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Reagents
  1. By Value
3. Peptide Synthesizers
  1. By Value
4. Resins
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Development
  1. By Value
3. Research and Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. Vaccine Development
  1. By Value
6. Others (Cosmetics, Food, and Agriculture)
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotech Companies
  1. By Value
3. Academic and Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Diagnostic Laboratories
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Solid-Phase Peptide Synthesis (SPPS)
  1. By Value
3. Liquid-Phase Peptide Synthesis (LPPS)
  1. By Value
4. Hybrid Synthesis
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Reagents
  1. By Value
3. Peptide Synthesizers
  1. By Value
4. Resins
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Development
  1. By Value
3. Research and Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. Vaccine Development
  1. By Value
6. Others (Cosmetics, Food, and Agriculture)
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotech Companies
  1. By Value
3. Academic and Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Diagnostic Laboratories
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Solid-Phase Peptide Synthesis (SPPS)
  1. By Value
3. Liquid-Phase Peptide Synthesis (LPPS)
  1. By Value
4. Hybrid Synthesis
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Reagents
    1. By Value
  3. Peptide Synthesizers
    1. By Value
  4. Resins
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Development
    1. By Value
  3. Research and Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. Vaccine Development
    1. By Value
  6. Others (Cosmetics, Food, and Agriculture)
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotech Companies
    1. By Value
  3. Academic and Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Diagnostic Laboratories
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Solid-Phase Peptide Synthesis (SPPS)
    1. By Value
  3. Liquid-Phase Peptide Synthesis (LPPS)
    1. By Value
  4. Hybrid Synthesis
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Reagents
  1. By Value
3. Peptide Synthesizers
  1. By Value
4. Resins
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Development
  1. By Value
3. Research and Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. Vaccine Development
  1. By Value
6. Others (Cosmetics, Food, and Agriculture)
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotech Companies
  1. By Value
3. Academic and Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Diagnostic Laboratories
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Solid-Phase Peptide Synthesis (SPPS)
  1. By Value
3. Liquid-Phase Peptide Synthesis (LPPS)
  1. By Value
4. Hybrid Synthesis
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Reagents
    1. By Value
  3. Peptide Synthesizers
    1. By Value
  4. Resins
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Development
    1. By Value
  3. Research and Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. Vaccine Development
    1. By Value
  6. Others (Cosmetics, Food, and Agriculture)
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotech Companies
    1. By Value
  3. Academic and Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Diagnostic Laboratories
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Solid-Phase Peptide Synthesis (SPPS)
    1. By Value
  3. Liquid-Phase Peptide Synthesis (LPPS)
    1. By Value
  4. Hybrid Synthesis
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Reagents
  1. By Value
3. Peptide Synthesizers
  1. By Value
4. Resins
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Development
  1. By Value
3. Research and Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. Vaccine Development
  1. By Value
6. Others (Cosmetics, Food, and Agriculture)
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotech Companies
  1. By Value
3. Academic and Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Diagnostic Laboratories
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Solid-Phase Peptide Synthesis (SPPS)
  1. By Value
3. Liquid-Phase Peptide Synthesis (LPPS)
  1. By Value
4. Hybrid Synthesis
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Reagents
    1. By Value
  3. Peptide Synthesizers
    1. By Value
  4. Resins
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Development
    1. By Value
  3. Research and Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. Vaccine Development
    1. By Value
  6. Others (Cosmetics, Food, and Agriculture)
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotech Companies
    1. By Value
  3. Academic and Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Diagnostic Laboratories
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Solid-Phase Peptide Synthesis (SPPS)
    1. By Value
  3. Liquid-Phase Peptide Synthesis (LPPS)
    1. By Value
  4. Hybrid Synthesis
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Reagents
  1. By Value
3. Peptide Synthesizers
  1. By Value
4. Resins
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Development
  1. By Value
3. Research and Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. Vaccine Development
  1. By Value
6. Others (Cosmetics, Food, and Agriculture)
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotech Companies
  1. By Value
3. Academic and Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Diagnostic Laboratories
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Solid-Phase Peptide Synthesis (SPPS)
  1. By Value
3. Liquid-Phase Peptide Synthesis (LPPS)
  1. By Value
4. Hybrid Synthesis
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Reagents
    1. By Value
  3. Peptide Synthesizers
    1. By Value
  4. Resins
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Development
    1. By Value
  3. Research and Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. Vaccine Development
    1. By Value
  6. Others (Cosmetics, Food, and Agriculture)
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotech Companies
    1. By Value
  3. Academic and Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Diagnostic Laboratories
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Solid-Phase Peptide Synthesis (SPPS)
    1. By Value
  3. Liquid-Phase Peptide Synthesis (LPPS)
    1. By Value
  4. Hybrid Synthesis
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Reagents
  1. By Value
3. Peptide Synthesizers
  1. By Value
4. Resins
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Drug Development
  1. By Value
3. Research and Diagnostics
  1. By Value
4. Therapeutics
  1. By Value
5. Vaccine Development
  1. By Value
6. Others (Cosmetics, Food, and Agriculture)
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Pharmaceutical and Biotech Companies
  1. By Value
3. Academic and Research Institutes
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Diagnostic Laboratories
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Solid-Phase Peptide Synthesis (SPPS)
  1. By Value
3. Liquid-Phase Peptide Synthesis (LPPS)
  1. By Value
4. Hybrid Synthesis
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Reagents
    1. By Value
  3. Peptide Synthesizers
    1. By Value
  4. Resins
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Drug Development
    1. By Value
  3. Research and Diagnostics
    1. By Value
  4. Therapeutics
    1. By Value
  5. Vaccine Development
    1. By Value
  6. Others (Cosmetics, Food, and Agriculture)
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Pharmaceutical and Biotech Companies
    1. By Value
  3. Academic and Research Institutes
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Diagnostic Laboratories
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Solid-Phase Peptide Synthesis (SPPS)
    1. By Value
  3. Liquid-Phase Peptide Synthesis (LPPS)
    1. By Value
  4. Hybrid Synthesis
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Peptide Synthesis Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Merck KGaA
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Thermo Fisher Scientific Inc.
GenScript
Novozymes A/S
Bachem Holding AG
MP Biomedicals
Lonza
PuroSynth
Syngene
Polypeptide Group
Creative Diagnostics
Thermo Fischer Scientific, Inc.
CEM Corporation
Biotage
Kaneka Corporation

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment